APA (7th ed.) Citation

Høibraaten, E., Qvigstad, E., Arnesen, H., Larsen, S., Wickstrøm, E., & Sandset, P. M. (2000). Increased risk of recurrent venous thromboembolism during hormone replacement therapy--results of the randomized, double-blind, placebo-controlled estrogen in venous thromboembolism trial (EVTET). Thrombosis and haemostasis, 84(6), 961. https://doi.org/10.1055/s-0037-1614156

Chicago Style (17th ed.) Citation

Høibraaten, E., E. Qvigstad, H. Arnesen, S. Larsen, E. Wickstrøm, and P M. Sandset. "Increased Risk of Recurrent Venous Thromboembolism During Hormone Replacement Therapy--results of the Randomized, Double-blind, Placebo-controlled Estrogen in Venous Thromboembolism Trial (EVTET)." Thrombosis and Haemostasis 84, no. 6 (2000): 961. https://doi.org/10.1055/s-0037-1614156.

MLA (9th ed.) Citation

Høibraaten, E., et al. "Increased Risk of Recurrent Venous Thromboembolism During Hormone Replacement Therapy--results of the Randomized, Double-blind, Placebo-controlled Estrogen in Venous Thromboembolism Trial (EVTET)." Thrombosis and Haemostasis, vol. 84, no. 6, 2000, p. 961, https://doi.org/10.1055/s-0037-1614156.